Topic: Breast Cancer Treatment
BusinessWeek | 2009-12-25 06:05:42
<div><h1>NEW HOPE FROM OLD DRUGS
</h1><p>Onyx Pharmaceuticals and Bayer said their Nexavar pill, sold in more than 70 countries to treat cancers of the liver and kidney, extended the lives of women with advanced breast cancer by delaying growth of malignancies that had spread or recurred. Tumors in ...
BusinessWeek | 2009-12-25 06:05:39
<div><h1>HERCEPTIN HELPS DELIVER A WARHEAD
</h1><p>Roche and ImmunoGen reported on a "guided missile" combination drug called T-DM1 that shrank tumors by 30% or more in one-third of critically ill, advanced breast cancer patients in a trial. The therapy combines Roche's Herceptin with a second, potent cancer-killing drug ...
Reuters US Online Report Health News | 2009-12-12 01:03:17
<div><p>CHICAGO (Reuters) - U.S. researchers may have found a way to overcome resistance to hormone-blocking breast cancer drugs, extending the life of treatments that keep the disease in check.</p><p>They said the drug Nexavar or sorafenib, made by German drugmaker Bayer and its development partner Onyx Pharmaceuticals, helped ...
AP News | 2009-12-12 00:38:22
<div id="subtitle">Novel drug combo boosts survival of breast cancer patients with advanced disease, study finds</div><div><p>Some women with very advanced breast cancer may have a new treatment option. A combination of two drugs that more precisely target tumors significantly extended the lives of women who had stopped ...
